Incidence and Predictors of Virological Failure Among Adult HIV/AIDS Patients on Second-Line Anti-Retroviral Therapy, in Selected Public Hospital of Addis Ababa, Ethiopia: Retrospective Follow-Up Study

References

• UNAIDS. Fast track strategy to end the AIDS epidemic by 2030; 2014.
   Google Scholar
• UNAIDS. UNAIDS data 2019; 2018.
   Google Scholar
• Roberts T, Cohn J, Bonner K, Hargreaves S. Scale-up of routine viral load testing in resource-poor settings: current and future implementation challenges. Clin Infect Dis. 2016;62(8):1043–1048. doi:10.1093/cid/ciw001
   PubMed Web of Science ®Google Scholar
• EthiopiaCountry Operational Plan. Strategic direction summary; 2018.
   Google Scholar
• Churchill D, Waters L, Ahmed N, et al. British HIV association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015. HIV Med. 2016;17(Suppl 4):s2–s104. doi:10.1111/hiv.12426
   PubMed Web of Science ®Google Scholar
• World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. World Health Organization; 2016.
   Google Scholar
• Boender TS, Hamers RL, Ondoa P, et al. Protease inhibitor resistance in the first 3 years of second-line antiretroviral therapy for HIV-1 in Sub-Saharan Africa. J Infect Dis. 2016;214(6):873–883. doi:10.1093/infdis/jiw219
   PubMed Web of Science ®Google Scholar
• FMOH Ethiopia. National consolidated guidelines for comprehensive HIV prevention, care and treatment; 2018.
   Google Scholar
• Assefa Y, Gilks CF, Lynen L, et al. Performance of the Antiretroviral Treatment Program in Ethiopia, 2005–2015: strengths and weaknesses toward ending AIDS. Int J Infect Dis. 2017;60:70–76. doi:10.1016/j.ijid.2017.05.012
   PubMed Web of Science ®Google Scholar
• Edessa D, Sisay M, Asefa F. Second-line HIV treatment failure in sub-Saharan Africa: a systematic review and meta-analysis. PLoS One. 2019;14(7):e0220159. doi:10.1371/journal.pone.0220159
   PubMed Web of Science ®Google Scholar
• Mulugeta A, Assefa H, Tewelde T, Dube L. Determinants of survival among HIV positive children on antiretroviral therapy in public hospitals, Addis Ababa, Ethiopia. Qual Prim Care. 2017;25(4):235–241.
   Google Scholar
• Ayana GM, Akalu TY, Ayele TA. Joint modeling of of tuberculosis and change in viral load over time among adult HIV/AIDS patients on anti-retroviral therapy at Zewditu Memorial Hospital in Addis Ababa, Ethiopia. HIV/AIDS. 2021;13:239. doi:10.2147/DHIV.S291872
   Google Scholar
• Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics. 1983;39(2):499–503. doi:10.2307/2531021
   PubMed Web of Science ®Google Scholar
• Tsegaye AT, Wubshet M, Awoke T, Addis Alene K. Predictors of treatment failure on second-line antiretroviral therapy among adults in northwest Ethiopia: a multicentre retrospective follow-up study. BMJ Open. 2016;6(12):e012537. doi:10.1136/bmjopen-2016-012537
   PubMed Web of Science ®Google Scholar
• Zenebe Haftu ADA, Bezabih NM, Bayray Kahsay A, et al. Incidence and factors associated with treatment failure among HIV infected adolescent and adult patients on second-line antiretroviral therapy in public hospitals of Northern Ethiopia: multicenter retrospective study. PLoS One. 2020;15(9):e0239191. doi:10.1371/journal.pone.0239191
   PubMed Web of Science ®Google Scholar
• Agegnehu CD, Merid MW, Yenit MK. Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study. BMC Infect Dis. 2020;20(1):460. doi:10.1186/s12879-020-05177-2
   PubMed Web of Science ®Google Scholar
• Seid A, Cherie N, Ahmed K. Determinants of virologic failure among adults on second line antiretroviral therapy in Wollo, Amhara Regional State, Northeast Ethiopia. HIV/AIDS. 2020;12:697–706.
   Google Scholar
• Nsanzimana S, Semakula M, Ndahindwa V, et al. Retention in care and virological failure among adult HIV+ patients on second-line ART in Rwanda: a national representative study. BMC Infect Dis. 2019;19(1):312. doi:10.1186/s12879-019-3934-2
   PubMed Web of Science ®Google Scholar
• Ongubo DM, Lim R, Tweya H, et al. A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi. BMC Infect Dis. 2017;17(1):461. doi:10.1186/s12879-017-2528-0
   PubMed Web of Science ®Google Scholar
• Gunda DW, Kilonzo SB, Mtaki T, Bernard DM, Kalluvya SE, Shao ER. Magnitude and correlates of virological failure among adult HIV patients receiving PI based second line ART regimens in north western Tanzania; a case control study. BMC Infect Dis. 2019;19(1):235. doi:10.1186/s12879-019-3852-3
   PubMed Web of Science ®Google Scholar
• Gunda DWKC, Kidenya BR, Kabangila R, et al. Plasma concentrations of efavirenz and nevirapine among HIV-infected patients with immunological failure attending a tertiary hospital in North-Western Tanzania. PLoS One. 2013;8(9):e75118. doi:10.1371/journal.pone.0075118
   PubMed Web of Science ®Google Scholar
• Alexander G. Chapter 34 Liver and biliary tract. In: Bennett PN, Brown MJ, Sharma P, editors. Clinical Pharmacology 11th ed. Oxford: Churchill Livingstone; 2012:546–556.
   Google Scholar
• Collier D, Iwuji C, Derache A, et al. Virological outcomes of second-line protease inhibitor-based treatment for human immunodeficiency virus type 1 in a high-prevalence rural South African setting: a competing-risks prospective cohort analysis. Clin Infect Dis. 2017;64(8):1006–1016. doi:10.1093/cid/cix015
   PubMed Web of Science ®Google Scholar
• Antagonists TN. LiverTox: clinical and research information on drug-induced liver injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases, Ed. Rifampin. Bethesda, MD, USA; 2012.
   Google Scholar
• Alene M, Awoke T, Yenit MK, Tsegaye AT. Incidence and predictors of second-line antiretroviral treatment failure among adults living with HIV in Amhara region: a multi-centered retrospective follow-up study. BMC Infect Dis. 2019;19(1):599. doi:10.1186/s12879-019-4243-5
   PubMed Web of Science ®Google Scholar
• Etenyi JO, Okalebo FA, Oluka M, et al. Comparison of zidovudine and tenofovir based regimens with regard to health-related quality of life and prevalence of symptoms in HIV patients in a Kenyan Referral Hospital. Front Pharmacol. 2018;9:984. doi:10.3389/fphar.2018.00984
   PubMed Web of Science ®Google Scholar
• Onoya D, Nattey C, Budgell E, et al. Predicting the need for third-line antiretroviral therapy by identifying patients at high risk for failing second-line antiretroviral therapy in South Africa. AIDS Patient Care STDS. 2017;31(5):205–212. doi:10.1089/apc.2016.0291
   PubMed Web of Science ®Google Scholar
• Mwangi A, van Wyk B. Factors associated with viral suppression among adolescents on antiretroviral therapy in Homa Bay County, Kenya: a retrospective cross-sectional study. HIV/AIDS. 2021;13:1111–1118.
   Google Scholar